BIRMINGHAM, Ala. (WIAT) – A new drug received full FDA approval for early-onset Alzheimer’s treatment. Alzheimer’s for Central Alabama says this is a step in the right direction for treatment and hopes with more research a cure can be found. “We had a drug that was approved last June, the first drug, Aduhelm, had a […]
UAB was involved in clinical trials that led to an accelerated approval of the drug lecanemab, commercially known as Leqembi, in January 2023. A UAB Alzheimer’s expert discusses the therapy and what full approval means f.
New findings show mitochondrial DNA fragments in blood as important biomarkers for aging and inflammation: High levels of cell free DNA circulating in blood is further linked to chronic inflammation, a well-known risk factor for severe aging symptoms and frailty in older adults sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.
In an eight-year study of more than 600 community-dwelling older adults, Johns Hopkins Medicine researchers say they have further linked levels of cell-free DNA (DNA fragments resulting from cell death) circulating in the blood to chronic inflammation and frailty.